𝔖 Scriptorium
✦   LIBER   ✦

πŸ“

Moyamoya Disease Update

✍ Scribed by Byung-Kyu Cho (editor), Teiji Tominaga (editor)


Publisher
Springer
Year
2010
Tongue
English
Leaves
382
Category
Library

⬇  Acquire This Volume

No coin nor oath required. For personal study only.

✦ Synopsis


Moyamoya disease (MMD) was first reported as a new entity among vascular disorders in 1957. Named for the abnormal vascular networks found around the occluded distal internal carotid artery, it is the most common pediatric cerebrovascular disease in East Asia. In recent years large amounts of data on MMD have been collected and important investigations have been carried out in Japan and Korea, even as the pathophysiology of the disease remains to be discovered. This monograph covers a diversity of topics and presents a systematic compilation of the data and current status of MMD in clinical practice and basic research. With contributions by more than 70 authors, the book includes sections on genetics, computational analysis of hemodynamic shear stress, new imaging techniques, and endovascular treatment of MMD, along with practical applications and future directions for gene and stem cell therapies. For neurosurgeons as well as neurologists and pediatricians, this volume will help lead to more efficient and informed management of MMD.

✦ Table of Contents


Moyamoya Disease Update
Title Page
Copyright Page
Foreword
Preface
Contents
Contributors
Part I: Introduction
Part II: Epidemiology
Part III: Genetics
Part IV: Pathophysiology I: Protein, Cell, and Immunology
Part V: Pathophysiology II: Hemodynamics, Biomechanical Aspect
Part VI: Clinical Features
Part VII: Diagnostic Evaluation I: Morphological Imaging
Part VIII: Diagnostic Evaluation II: Functional Imaging
Part IX: Diagnostic Evaluation III: Electrophysiology
Part X: Surgical Technique
Part XI: Surgical Outcome
Part XII: Special Consideration I
Part XIII: Special Consideration II
Part XIV: Special Consideration III
Part XV: Future Perspectives
Index


πŸ“œ SIMILAR VOLUMES


Moyamoya Disease Update
✍ Teiji Tominaga (auth.), Byung-Kyu Cho, Teiji Tominaga (eds.) πŸ“‚ Library πŸ“… 2010 πŸ› Springer Japan 🌐 English

<p>Moyamoya disease (MMD) was first reported as a new entity among vascular disorders in 1957. Named for the abnormal vascular networks found around the occluded distal internal carotid artery, it is the most common pediatric cerebrovascular disease in East Asia. In recent years large amounts of dat

Moyamoya Disease
✍ Professor Jiro Suzuki M.D. (auth.) πŸ“‚ Library πŸ“… 1986 πŸ› Springer-Verlag Berlin Heidelberg 🌐 English

<p>The first mention of moyamoya disease as a distinct disease entity was in a paper I published in 1965. The abnormal netΒ­ like vessels at the base of the brain seen in cerebral angioΒ­ grams of this disease were described by most native speakers of Japanese as "moyamoya," a Japanese expression for

Moyamoya Disease: Diagnosis and Treatmen
✍ John E. Wanebo (editor), Nadia Khan (editor), Joseph M. Zabramski (editor), Robe πŸ“‚ Library πŸ“… 2013 πŸ› Thieme 🌐 English

<p><em>Moyamoya Disease: Diagnosis and Treatment</em> covers the key clinical disciplines involved in managing patients with moyamoya disease, including diagnostic work up, imaging, neurocognitive evaluation, and surgical options for pediatric and adult patients. The text and accompanying videos pro

Moyamoya Disease: Current Knowledge and
✍ Satoshi Kuroda (editor) πŸ“‚ Library πŸ“… 2021 πŸ› Springer 🌐 English

<p></p><p><span>This book brings together the latest knowledge on moyamoya disease, covering diagnostic criteria, status as a disease entity, genetic aspects, pathophysiology, novel neuroradiological findings, and surgical therapy. Information is also provided on recent basic and clinical research w

Moyamoya Disease Explored Through RNF213
✍ Akio Koizumi, Kazuhiro Nagata, Kiyohiro Houkin, Teiji Tominaga, Susumu Miyamoto, πŸ“‚ Library πŸ“… 2017 πŸ› Springer Singapore 🌐 English

<p>This book presents the latest findings on biological, epidemiological, and clinical investigations of <i>RNF213</i>, which is thought to be involved in many biological processes and plays a key role in cerebro- and cardiovascular disease . By discussing the epidemiology and genetic epidemiology o